SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001011438-16-000459
Filing Date
2016-02-16
Accepted
2016-02-16 16:35:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 form_sc13ga-vanda.htm SC 13G/A 68700
  Complete submission text file 0001011438-16-000459.txt   70296
Mailing Address 1251 AVENUE OF THE AMERICAS NEW YORK NY 10020
Business Address 1251 AVENUE OF THE AMERICAS NEW YORK NY 10020 212-956-2221
PAULSON & CO. INC. (Filed by) CIK: 0001035674 (see all company filings)

IRS No.: 133796759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Subject) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-82196 | Film No.: 161429304
SIC: 2834 Pharmaceutical Preparations